Summary & Overview
CPT 0584T: Pancreatic Islet Cell Transplantation, Intraportal Infusion
CPT code 0584T denotes pancreatic beta islet cell transplantation by infusion into the portal vein, performed to stimulate endogenous insulin production in patients with diabetes. This advanced interventional transplant procedure combines surgical access and image-guided radiologic infusion, with imaging and radiology services bundled into the code. Nationally, the code matters because it captures a specialized therapy with implications for transplant program coverage, payer policy development, and access to emerging biologic treatments.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for islet cell infusion procedures, typical sites of service, and the scope of services captured by the code. The publication summarizes payer coverage patterns and policy considerations, reimbursement benchmarks where available, coding and billing guidance related to bundled imaging and supervision, and relevant clinical indications that drive utilization. It also highlights areas where data are limited or variable and where policy clarification is commonly sought.
The content is intended for hospital billing managers, transplant program administrators, clinicians involved in islet cell therapy, and payer policy analysts seeking a concise national view of how CPT code 0584T is used and reimbursed across major payers.
Billing Code Overview
CPT code 0584T describes a pancreatic islet cell transplantation procedure in which pancreatic beta islet cells, sourced from the patient or a donor, are transplanted to stimulate insulin production in a patient with diabetes. The provider infuses the islet cells into the portal vein of the liver through a catheter inserted via a small abdominal skin incision. All imaging, imaging guidance, and radiological supervision and interpretation are included with this procedure.
-
Service type: Surgical/interventional transplant procedure involving intra-portal infusion of pancreatic islet cells
-
Typical site of service: Hospital operating room or interventional radiology suite with inpatient or outpatient admission depending on clinical need
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient with type 1 diabetes refractory to optimized medical therapy and recurrent severe hypoglycemia undergoes autologous or allogeneic pancreatic beta islet cell transplantation. The multidisciplinary workflow begins with pre-procedure assessment by endocrinology and transplant surgery or interventional radiology: medical optimization, infectious disease screening, donor screening if allogeneic, and informed consent. On the day of the procedure the patient is brought to an interventional radiology or hybrid operating suite. Under conscious sedation or general anesthesia, the operator obtains image guidance (usually ultrasound and fluoroscopy) to access the portal venous system via a percutaneous transhepatic or transabdominal approach through a small abdominal skin incision. The islet cell preparation is infused slowly into the portal vein through a catheter or introducer; portal pressures are monitored. Radiological supervision and interpretation, intraoperative imaging, and any necessary fluoroscopic guidance are provided as part of the service. Post-procedure monitoring includes observation for bleeding, portal vein thrombosis, and graft function in an inpatient or ambulatory infusion recovery area. Typical sites of service are an interventional radiology suite, hybrid operating room, or hospital inpatient surgical unit depending on anesthesia and monitoring needs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for and documentation supports increased complexity. |